13 November 2015

Optimising Gene Medicine Delivery for Duchenne Muscular Dystrophy

Organised by:

SCI's Biotechnology Group in partnership with the University of Westminster

University of Westminster

Registration Closed

This event is no longer available for registration.

Delivery of therapeutic gene medicines is a fundamental problem that hinders the developmental pipeline of many translational programmes. Viral vectors and antisense oligonucleotides are both at the forefront of therapeutic programmes for Duchenne muscular dystrophy. The presentation will focus on (i) approaches to delivery full length dystrophin; a large gene cargo and (ii) optimising the delivery of antisense oligonucleotide to restore dystophin expression.
Venue and Contact

University of Westminster

University of Westminster
School of Life Sciences
115 New Cavendish Street
London W1W 6UW

Please click here for a location map.

SCI Comms Team

Tel: +44 (0) 20 7598 1594

Email: communications@soci.org

This is a free event, no need to book. Please check this page for any updates or changes before attending the event.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

CPD logo 2021-2023

Additional Info


Dr Keith Foster
Associate Professor in Translational Medicine, School of Biological Sciences, University of Reading